News
Novartis AG beats Q2 2025 expectations, but patent expiries and policy risks loom. Click for my updated look at NVS earnings ...
Tesla expected to post double-digit declines in earnings, sales. Fed chief Powell speech in focus as central bank ...
Wall Street analysts predict lower second-quarter profits for Ford, GM and Stellantis due to tariff pressures and slowing sales.
6d
Zacks Investment Research on MSNHow Will Pfizer's Oncology Drugs Perform in Q2 Earnings?Pfizer PFE is one of the biggest players in the oncology space — a position it strengthened with the 2023 acquisition of Seagen. The deal added four antibody-drug conjugates (ADC) — Adcetris, Padcev, ...
1d
TipRanks on MSNThe Week That Was, The Week Ahead: Macro & Markets, July 20, 2025Everything to Know about Macro and Markets The S&P 500 (SPX) and the Nasdaq-100 (NDX) inched down from Thursday’s record highs, though still ...
American Express stock has been stable but unspectacular this year, staying in lockstep with the broader market. With ...
Mizuho raised Applied Materials’ price target to $220 while keeping its “Outperform” rating, betting big on semiconductor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results